arrow
K

Kenneth W. Merrell

Mayo Clinic
H指数:25
被引数:1,917

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Increasing the Response of Mismatch Repair Proficient Rectal Cancer to Immunotherapy with Particle Radiation and DNA Damage Response Inhibitors-Preclinical Evidence

通过粒子辐射和DNA损伤反应抑制剂提高错配修复功能完整的直肠癌对免疫治疗的反应性——临床前证据

Cancers
IF4.4
2026-02-190
OAAI
Clinical Evidence on Particle Radiation, DNA Damage Response Inhibitors, and Immunotherapy for Mismatch Repair-Proficient Rectal Cancer

Salazar-Vilches, C.J.; Ebner, D.K.; Kloeber, J.A.; Dragojevic, S.; Singh, J.; Haddock, M.; Sharifzadeh, Y.; Sherry, A.D.; Jethwa, K.R.; Hallemeier, C.L.; et al. 关于粒子辐射、DNA损伤反应抑制剂和免疫疗法在错配修复能力正常的直肠癌中的临床证据。Cancers 2026, 18, 652. [Google Scholar] [CrossRef] [PubMed]

Cancers
IF4.4
2026-02-171
OAAI
Long Term Outcomes after Re-Irradiation With Spine Stereotactic Body Radiation Therapy: Single Institutional Retrospective Experience

脊柱立体定向体部放射治疗再程照射后的长期结果:单机构回顾性经验

2025-09-030
OAAI
Linear energy transfer optimized proton therapy for rectal cancer

直肠癌症的线性能量传递优化质子疗法

2025-06-010
OAAI
Assessment of minimum target dose as a predictor of local failure after spine SBRT
2024-06-014
PRE
Sublobar Resection, Stereotactic Body Radiation Therapy, and Percutaneous Ablation Provide Comparable Outcomes for Lung Metastasis-Directed Therapy
CHEST
IF8.6
2024-05-012
PRE
Determining the Minimal Clinically Important Difference of the Functional Assessment of Cancer Therapy Hepatobiliary Questionnaire to Evaluate the Change in the Quality of Life of Patients With Pancreatic Cancer During Radiation Therapy
2024-01-011
PRE
Development and validation of a unifying pre-treatment decision tool for intracranial and extracranial metastasis-directed radiotherapy
2023-03-271
OAAI
Development and validation of a recursive partitioning analysis-based pretreatment decision-making tool identifying ideal candidates for spine stereotactic body radiation therapy
CANCER
IF5.1
2022-12-266
PRE
Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer
2022-12-0117
PRE